http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108823139-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2402 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24 |
filingDate | 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108823139-B |
titleOfInvention | A strain of Escherichia coli producing heparinase and its construction method and application |
abstract | The invention provides a strain of Escherichia coli BLR(DE3)-pBENT-H1 that produces heparinase, which belongs to the technical field of the construction of genetically engineered bacteria, and the deposit number is CGMCC No.15819. The heparinase-producing Escherichia coli provided by the invention can produce heparinase, and the enzymatic activity of heparinase is 2540U/L. The obtained heparinase is enzymatically hydrolyzed heparin, and the weight average of the obtained ultra-low molecular weight heparin is obtained. The molecular weight is 1419Da, and the Anti-FXa/Anti-FIIa titer ratio of low molecular weight heparin is 28.4. |
priorityDate | 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 261.